Ryan Maynard : Blade Therapeutics CFO
Accounting alumnus Ryan Maynard '91 was appointed Chief Financial Officer of Blade Therapeutics, a biopharmaceutical company. Staying within the same industry, Maynard was Executive Vice President and CFO of Rigel Pharmaceuticals before going to Blade Therapeutics. Maynard has over sixteen years of experience in the financial field.
“We are delighted to welcome Ryan to Blade,” stated Blade’s Chief Executive Officer, Wendye Robbins, M.D in a recent press release. “He is an accomplished executive with strong financial leadership and a proven record of financing biopharmaceutical companies, and we believe he will be a great addition to our executive team.”
Read the full article»
Feb 27, 2018